Birch Pollen Induced Allergic Rhinoconjunctivitis clinical trials

Explore recruiting birch pollen induced allergic rhinoconjunctivitis clinical trials.

Also recruiting in Europe

Birch Pollen Induced Allergic Rhinoconjunctivitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multi-national Phase IIIb, Double-blind, Placebo-controlled Trial to Determine the Safety and Efficacy of STALORAL® Birch 300 IR in Children and Adolescents 5 to 17 Years old with Birch Pollen-induced Allergic Rhinoconjunctivitis with or without Asthma

Finland, Slovakia, Germany, Sweden, Austria, Romania +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered subcutaneously to adolescents and adults with birch pollen-induced allergic rhinitis or rhinoconjunctivitis.

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Birch Pollen Induced Allergic Rhinoconjunctivitis trials by city

Birch Pollen Induced Allergic Rhinoconjunctivitis in Toronto Birch Pollen Induced Allergic Rhinoconjunctivitis in Vancouver Birch Pollen Induced Allergic Rhinoconjunctivitis in Montreal Birch Pollen Induced Allergic Rhinoconjunctivitis in Calgary Birch Pollen Induced Allergic Rhinoconjunctivitis in Edmonton Birch Pollen Induced Allergic Rhinoconjunctivitis in Ottawa Birch Pollen Induced Allergic Rhinoconjunctivitis in Winnipeg Birch Pollen Induced Allergic Rhinoconjunctivitis in Quebec City Birch Pollen Induced Allergic Rhinoconjunctivitis in Hamilton Birch Pollen Induced Allergic Rhinoconjunctivitis in Kitchener Birch Pollen Induced Allergic Rhinoconjunctivitis in London Birch Pollen Induced Allergic Rhinoconjunctivitis in Halifax Birch Pollen Induced Allergic Rhinoconjunctivitis in New York Birch Pollen Induced Allergic Rhinoconjunctivitis in Los Angeles Birch Pollen Induced Allergic Rhinoconjunctivitis in Chicago Birch Pollen Induced Allergic Rhinoconjunctivitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease